Khalid Nabilsi Insider Profile
4 Followers
Khalid Nabilsi, Regional Chief Executive Officer at Hikma Pharmaceuticals, holds 549.38K shares in Hikma Pharmaceuticals (Ticker: GB:HIK).
Khalid Nabilsi's Trading History
| HIKHikma Pharmaceuticals | Jun 02, 2026 | Regional Chief Executive Officer | Uninformative Buy | ― | £9.03M | |||||||||||||||||||||||||||||||||||||||||||
GB:HIK Insider Shares: 549.38K (25.58%)
| ||||||||||||||||||||||||||||||||||||||||||||||||
You May Also Like
Khalid Nabilsi insider profile FAQ
What is the percentage of profitable transactions made by Khalid Nabilsi?
The percentage of profitable transactions made by Khalid Nabilsi is 83%.
What is the average return per transaction made by Khalid Nabilsi?
The average return per transaction made by Khalid Nabilsi is 17.20%.
What stocks does Khalid Nabilsi hold?
Khalid Nabilsi holds: GB:HIK stocks.
What was Khalid Nabilsi's most profitable transaction?
Khalid Nabilsi’s most profitable transaction was an Informative Sell of GB:HIK stock on April 28, 2017. The return on the trade was 30.20%.
What is Khalid Nabilsi's role in Hikma Pharmaceuticals?
Khalid Nabilsi's role in Hikma Pharmaceuticals is Regional Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
